{"disease":{"id":"growth-hormone-disorder","name":"growth hormone disorder"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01009905","title":"An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)","phase":"","overall_status":"COMPLETED","enrollment_count":22960,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT00960128","title":"Observational Prospective Study on Patients Treated With Norditropin®","phase":"","overall_status":"COMPLETED","enrollment_count":21249,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT06037473","title":"The Efficacy and Safety of PEGylated GH for the Treatment of Short Stature in Chinese Children-GLOBE Reg","phase":"","overall_status":"RECRUITING","enrollment_count":2600,"lead_sponsor_name":"Beijing Children's Hospital","has_results":false},{"nct_id":"NCT01580605","title":"French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin","phase":"","overall_status":"COMPLETED","enrollment_count":331,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT02229851","title":"Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":301,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT00567385","title":"Liquid Somatropin Formulation in Children With Growth Hormone Deficiency","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":176,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT01563926","title":"Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":168,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT05144035","title":"A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":138,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT00519558","title":"Growth Hormone Deficiency in Adults (GHDA)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":121,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT00184743","title":"Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":112,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT01514500","title":"First Human Dose Trial of NNC0195-0092 (Somapacitan) in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT02382939","title":"A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT00931476","title":"A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Somatropin","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT01502124","title":"Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT02616562","title":"Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":76,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT03075644","title":"A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT03186495","title":"Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT02413138","title":"Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317)","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":41,"lead_sponsor_name":"Versartis Inc.","has_results":false},{"nct_id":"NCT01706783","title":"A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT03212131","title":"Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Mild and Moderate Degrees of Hepatic Impairment Compared to Subjects With Normal Hepatic Function.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT01973244","title":"A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (Somapacitan) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT01562834","title":"Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT01698944","title":"Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone Deficiency","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false}],"total":23},"guidelines":[],"source":"Drug Landscape verified database"}